七叶皂苷钠片联合泼尼松治疗特发性面神经麻痹临床效果观察

骆嵩; 王晓蕊; 马博; 屈洪党

doi:10.16766/j.cnki.issn.1674-4152.003452

七叶皂苷钠片联合泼尼松治疗特发性面神经麻痹临床效果观察

doi: 10.16766/j.cnki.issn.1674-4152.003452

蚌埠医科大学第一附属医院神经内科，安徽蚌埠 233004

基金项目:

安徽省临床医学研究转化专项项目 202304295107020076

安徽省教育厅重点项目 2022AH051480

安徽省“江淮名医”培育工程项目 2022

详细信息

通讯作者:
屈洪党，E-mail：qhd820@sohu.com

中图分类号: R745.12
计量
- 文章访问数: 48
- HTML全文浏览量: 12
- PDF下载量: 7
- 被引次数: 0
出版历程
- 收稿日期: 2023-04-13
- 网络出版日期: 2024-05-29

Clinical effect observation of prednisone combined with sodium aescinate tablets in the treatment of facial neuritis

Department of Neurology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233004, China

摘要

摘要: 目的观察七叶皂苷钠片联合泼尼松治疗急性特发性面神经麻痹患者的效果，探讨该方案治疗特发性面神经麻痹的临床价值。方法选取2020年1月—2022年12月就诊于蚌埠医科大学第一附属医院神经内科的特发性面神经麻痹患者60例作为研究对象，应用随机数字表法将患者分为观察组和对照组，每组30例。对照组采用常规治疗，观察组在常规治疗的基础上加用七叶皂苷钠片。治疗30 d后，比较2组患者治疗后面神经功能评分、House-Brackman(H-B)分级并记录用药期间不良事件发生情况。结果观察组患者临床治疗后基本痊愈9例(30.0%)，显效10例(33.3%)，有效9例(30.0%)，无效2例(6.7%)，对照组患者临床治疗后基本痊愈7例(23.3%)，显效9例(30.0%)，有效6例(20.0%)，无效8例(26.7%)，2组治疗总有效率比较差异有统计学意义(P < 0.05)；观察组患者治疗后面神经功能评分为(69.33±14.41)分，高于对照组[(61.63±9.45)分]，2组比较差异有统计学意义(P < 0.05)；2组患者治疗后H-B分级比较差异无统计学意义(P>0.05)；2组患者在临床治疗过程中不良事件发生率比较差异无统计学意义(P>0.05)。结论七叶皂苷钠片联合泼尼松可以促进特发性面神经麻痹功能改善，且具有较好的安全性。
- 特发性面神经麻痹 /
- 泼尼松 /
- 七叶皂苷钠片
Abstract: Objective To explore the clinical efficacy of combining sodium aescinate tablets with prednisone in the treatment of facial neuritis and to explore the clinical value of this scheme in treating facial neuritis. Methods This study enrolled 60 patients with facial neuropathy from January 2020 to December 2022 at the Department of Neurology, the First Affiliated Hospital of Bengbu Medical University. The patients were randomly divided into two groups using a random number table method: the control group (n=30) received conventional treatment, while the observation group (n=30) received conventional therapy along with the addition of sodium aescinate tablets. After a 30-day treatment period, the clinical effects were assessed by comparing neural function scores, House-Brackman (H-B) rating, and record adverse events between the two groups. Results Following clinical treatment, the observation group showed 9 patients achieving complete recovery (30.0%), 10 patients with significant improvement (33.3%), 9 were effective (30.0%), and 2 patients with no improvement (6.7%). In the control group, 7 patients achieved complete recovery (23.3%), 9 patients showed significant improvement (30.0%), 6 patients had moderate improvement (20.0%), and 8 patients showed no improvement (26.7%). The difference in total effective rate between the two groups was statistically significant (P < 0.05). The mean score of the patients in the observation group was 69.33±14.41, which was higher than that in the control group (61.63±9.45) after treatment, with a statistical difference (P < 0.05). There was no significant difference in H-B grade between the observation group and the control group (P>0.05). Additionally, no significant difference in adverse events was observed between the observation group and the control group (P>0.05). Conclusion The combination of sodium aescinate tablets and propionate promotes improved facial neuropathic function and enhances safety.
- Facial neuritis /
- Prednisone /
- Sodium aescinate tablets

HTML全文

表 1 2组特发性面神经麻痹患者一般临床资料比较

Table 1. Comparison of general clinical data between two groups of patients with facial neuritis

组别	例数	发病部位(左侧, 例)	入院H-B分级[例(%)]
组别	例数	发病部位(左侧, 例)	Ⅲ	Ⅳ	Ⅴ	Ⅵ
观察组	30	14	5(16.67)	8(26.67)	12(40.00)	5(16.67)
对照组	30	16	4(13.33)	9(30.00)	11(36.67)	6(20.00)
统计量		0.267^a	-0.232^b
P值		0.606	0.816
注：^a为χ²值，^b为Z值。

下载: 导出CSV

表 2 2组特发性面神经麻痹患者治疗后临床疗效比较[例(%)]

Table 2. Comparison of clinical curative effect between two groups of patients with facial neuritis after treatment[cases(%)]

组别	例数	基本痊愈	显效	有效	无效	总有效
观察组	30	9(30.0)	10(33.3)	9(30.0)	2(6.7)	28(93.3)
对照组	30	7(23.3)	9(30.0)	6(20.0)	8(26.7)	22(73.3)
注：2组疗效比较，Z=-1.235, P=0.217；2组总有效率比较，χ²=4.320，P=0.038。

下载: 导出CSV

表 3 2组特发性面神经麻痹患者治疗前后面神经功能评分比较(x ± s, 分)

Table 3. Comparison of neural function scores between two groups of patients with facial neuritis before and after treatment(x ± s, points)

组别	例数	治疗前	治疗后
观察组	30	27.60±8.72	69.33±14.41^b
对照组	30	29.33±8.38	61.63±9.45^b
统计量		0.738^a	5.268^c
P值		0.463	0.025
注：^a为t值，^c为F值。与同组治疗前比较，^bP < 0.01。

下载: 导出CSV

表 4 2组特发性面神经麻痹患者治疗后H-B分级比较[例(%)]

Table 4. Comparison of H-B grade between two groups of patients with facial neuritis after treatment[cases(%)]

组别	例数	Ⅰ级	Ⅱ级	Ⅲ级	Ⅳ级及以上
观察组	30	5(16.7)	15(50.0)	5(16.7)	5(16.7)
对照组	30	4(13.3)	13(43.3)	3(10.0)	10(33.3)
注：2组H-B分级比较，Z=-1.026, P=0.305。

下载: 导出CSV

表 5 2组特发性面神经麻痹患者治疗过程中不良事件发生率比较[例(%)]

Table 5. Comparison of incidence of adverse events during treatment in 2 two groups of patients with facial neuritis[cases(%)]

组别	例数	皮疹	头晕头痛	腹泻便秘
观察组	30	3(10.0)	3(10.0)	2(6.7)
对照组	30	2(6.7)	1(3.3)	1(3.3)
χ²值		< 0.001	0.268	< 0.001
P值		0.999	0.605	0.999

下载: 导出CSV

参考文献(18)

[1]	SPENCER C R, IRVING R M. Causes and management of facial nerve palsy[J]. Br J Hosp Med(Lond), 2016, 77(12): 686-691. doi: 10.12968/hmed.2016.77.12.686
[2]	刘晓芳, 郝风玲. 面神经炎的中西医联合治疗的研究概况[J]. 中国中医药现代远程教育, 2022, 20(13): 206-208. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYY202213077.htm LIU X F, HAO F L. Research Overviewof Integrated Traditional Chinese and Western Medicine in the Treatment of Facial Neuritis[J]. Chinese Medicine Modern Distance Education of China, 2022, 20(13): 206-208. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYY202213077.htm
[3]	马艳玲. 面神经炎中西医治疗进展[J]. 湖北民族大学学报(医学版), 2020, 37(4): 52-54. https://www.cnki.com.cn/Article/CJFDTOTAL-FBMZ202004012.htm MA Y L. Progress in treatment of facial neuritis with traditional Chinese and Western medicine[J]. Journal of Hubei Minzu University(Medical Edition), 2020, 37(4): 52-54. https://www.cnki.com.cn/Article/CJFDTOTAL-FBMZ202004012.htm
[4]	任丽丽, 王武庆, 伍伟景, 等. 七叶皂苷钠治疗梅尼埃病的临床初步研究报告[J]. 中华耳科学杂志, 2023, 21(1): 6-10. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHER202301002.htm REN L L, WANG W Q, WU W J, et al. Preliminary Results of Sodium Aescinate in Treatment of Meniere's Disease[J]. Chinese Journal of Otology, 2023, 21(1): 6-10. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHER202301002.htm
[5]	官泽宇, 宋涛, 余朝文, 等. 七叶皂苷钠对氧化型低密度脂蛋白诱导的血管平滑肌细胞增殖和迁移的影响[J]. 中国临床药理学杂志, 2023, 39(5): 639-643. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202305007.htm GUANG Z Y, SONG T, YU C W, et al. Effects of sodium aescinate on proliferation and migration of oxidized low-density lipoprotein induced vascular smooth muscle cells[J]. The Chinese Journal of Clinical Pharmacology, 2023, 39(5): 639-643. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202305007.htm
[6]	张瑞彪, 罗永伟, 石秋艳. 阿托伐他汀钙联合七叶皂甙钠对自身免疫性脑脊髓炎大鼠血清炎症因子水平及脊髓内病变的影响[J]. 中国老年学杂志, 2018, 38(2): 300-302. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ201802018.htm ZHANG R B, LUO Y W, SHI Q Y. Effects of atorvastatin calcium combined with sodium heptafolinate on serum levels of inflammatory factors and spinal cord lesions in autoimmune encephalomyelitis rats[J]. Chinese Journal of Gerontology, 2018, 38(2): 300-302. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ201802018.htm
[7]	杨计策, 杨永敏, 刘德政, 等. β-七叶皂甙钠静滴治疗神经根型颈椎病疗效观察[J]. 山东医药, 2015, 55(11): 77-78. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201511035.htm YANG J C, YANG Y M, LIU D Z, et al. Effect of intravenous drip of sodium aescinate on cervical spondylotic radiculopathy[J]. Shandong Medical Journal, 2015, 55(11): 77-78. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201511035.htm
[8]	郑茂平, 陈华东, 李绍波. 七叶皂苷钠对脊髓半横断损伤大鼠后肢运动功能的影响[J]. 现代医药卫生, 2014, 30(22): 3372-3373, 3376. https://www.cnki.com.cn/Article/CJFDTOTAL-XYWS201422009.htm ZHENG M P, CHEN H D, LI S B. Influence of sodium aescinate on hindlimb movement in rats with hemisection of spinal cord injury[J]. Journal of Modern Medicine & Health, 2014, 30(22): 3372-3373, 3376. https://www.cnki.com.cn/Article/CJFDTOTAL-XYWS201422009.htm
[9]	秦树巧, 黑丹丹. β-七叶皂苷钠辅助溶栓治疗对急性脑梗死病人血清miR-155与miR-181c表达的影响[J]. 中西医结合心脑血管病杂志, 2022, 20(16): 3042-3044. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202216045.htm QIN S Q, HEI D D. β-Influence of beta-heptadioloside sodium on serum miR-155 and miR-181c expression in patients with acute cerebral infarction[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease, 2022, 20(16): 3042-3044. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202216045.htm
[10]	于涛. 七叶皂苷钠与甘油果糖用于脑出血患者降颅压治疗的效果比较[J]. 中国民康医学, 2022, 34(15): 142-145. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMYX202215042.htm YU T. Comparison of effects of Sodium aescinate and Glycerol fructose for lowering intracranial pressure in patients with cerebral hemorrhage[J]. Medical Journal of Chinese People's Health, 2022, 34(15): 142-145. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMYX202215042.htm
[11]	卜云芸, 陈琳, 戴宜武, 等. 中国特发性面神经麻痹神经修复治疗临床指南(2022版)[J]. 神经损伤与功能重建, 2023, 18(1): 1-12. https://www.cnki.com.cn/Article/CJFDTOTAL-GWKF202301001.htm BU Y Y, CHEN L, DAI Y W, et al. Clinical Guidelines for the Repair of Idiopathic Facial Paralysis in China (2022 Edition)[J]. Neural Injury and Functional Reconstruction, 2023, 18(1): 1-12. https://www.cnki.com.cn/Article/CJFDTOTAL-GWKF202301001.htm
[12]	中华医学会神经病学分会, 中华医学会神经病学分会神经肌肉病学组, 中华医学会神经病学分会肌电图与临床神经电生理学组. 中国特发性面神经麻痹诊治指南[J]. 中华神经科杂志, 2016, 49(2): 84-86. https://www.cnki.com.cn/Article/CJFDTOTAL-GWKF202301001.htm Chinese Medical Association Neurology Branch, Chinese Medical Association Neurology Branch Neuromyopathy Group, Chinese Medical Association Neurology Branch Electromyography and Clinical Neurophysiology Group. Guidelines for diagnosis and treatment of Idiopathic facial paralysis in China[J]. Chinese Journal of Neurology, 2016, 49(2): 84-86. https://www.cnki.com.cn/Article/CJFDTOTAL-GWKF202301001.htm
[13]	高志强. 面神经功能评价标准(讨论稿)[J]. 中华耳鼻咽喉头颈外科杂志, 2006, 41(1): 22-24. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHEB200601006.htm GAO Z Q. Evaluation criteria of facial nerve Function (Discussion Draft)[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2006, 41(1): 22-24. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHEB200601006.htm
[14]	MALHOTRA V, DAYASHANKARA RAO J K, ARYA V, et al. Assessment of facial nerve injury with "House and Brackmann facial nerve grading system" in patients of temporomandibular joint ankylosis operated using deep subfascial approach[J]. Natl J Maxillofac Surg, 2015, 6(2): 194-199.
[15]	赵朋涛, 闫聚瀚, 闫晓冬, 等. 七叶皂苷钠对肾缺血再灌注的保护作用及机制[J]. 神经药理学报, 2022, 12(5): 17-23. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJKB202205003.htm ZHAO P T, YAN J H, YAN X D, et al. Protective Effect and Mechanism of Sodium Aescinate on Renal Ischemia Reperfusion[J]. Acta Neuropharmacologica, 2022, 12(5): 17-23. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJKB202205003.htm
[16]	张涛, 徐文昱, 周素敏. 泼尼松联合七叶皂苷钠治疗面神经炎的疗效及对调节性T细胞/辅助性T细胞17细胞因子、自由基生成的影响[J]. 中国药物经济学, 2021, 16(3): 95-98. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYWA202103024.htm ZHANG T, XU W Y, ZHOU S M. Efficacy of Prednisone Combined with Sodium Aescinate in the Treatment of Facial Neuritis and Their Effect on the Production of Treg/Th17 Cytokines and Free Radicals[J]. China Journal of Pharmaceutical Economics, 2021, 16(3): 95-98. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYWA202103024.htm
[17]	顾泉, 周林, 段波. 泼尼松与β-七叶皂苷钠对急性面神经炎患者功能恢复及肌电图的影响对比[J]. 世界临床药物, 2022, 43(4): 425-430, 448. https://www.cnki.com.cn/Article/CJFDTOTAL-GWHH202204011.htm GU Q, ZHOU L, DUAN B. Effects of prednisone and β-aescinate sodium on functional recovery and electromyography in patients with acute facial neuritis[J]. World Clinical Drug, 2022, 43(4): 425-430, 448. https://www.cnki.com.cn/Article/CJFDTOTAL-GWHH202204011.htm
[18]	赵紫楠, 赵飞, 李婷, 等. 注射用七叶皂苷钠的药品临床综合评价[J]. 中国医院用药评价与分析, 2022, 22(9): 1109-1113. https://www.cnki.com.cn/Article/CJFDTOTAL-YYPF202209020.htm ZHAO Z N, ZHAO F, LI T, et al. Comprehensive Clinical Evaluation of Sodium Aescinate for Injection[J]. Evaluation and Analysis of Drug-use in Hospitals of China, 2022, 22(9): 1109-1113. https://www.cnki.com.cn/Article/CJFDTOTAL-YYPF202209020.htm